| | |
No. of complications
|
No. of outliers
|
|---|
|
Study
|
Methodological quality
|
Study group
|
Control group
|
OR (95% CI)
|
Study group
|
Control group
|
OR (95% CI)
|
|---|
|
MIS
| | | | | | | |
|
Lawlor et al. [31]†
|
High
|
3/109
|
4/110
|
0.75 (0.16, 3.43)
| | |
NR
|
|
Chimento et al. [4]
|
High
|
3/28
|
2/32
|
1.80 (0.28, 11.64)
|
0
|
0
|
-
|
|
Ogonda et al. [34]†
|
High
|
3/109
|
6/110
|
0.75 (0.16, 3.43)
|
16/105
|
19/109
|
0.85 (0.41, 1.76)
|
|
Kim [30]
|
High
|
3/70
|
2/70
|
1.52 (0.25, 9.40)
|
13/70
|
11/70
|
1.22 (0.51, 2.95)
|
|
Chung et al. [23]
|
Medium
|
3/57
|
5/55
|
0.58 (0.13, 2.54)
|
0
|
0
|
-
|
|
Khan et al. [29]
|
Medium
|
15/100
|
21/100
|
0.66 (0.32, 1.38)
|
3/100
|
3/100
|
1.00 (0.20, 5.08)
|
|
Dorr et al. [26]
|
Medium
|
2/30
|
3/30
|
0.64 (0.10, 4.15)
|
0
|
0
|
-
|
|
Ciminiello et al. [24]
|
Medium
|
0
|
0
|
-
|
0
|
0
|
-
|
|
Dutka et al. [27]
|
Medium
|
1/60
|
1/60
|
1.00 (0.06, 16.37)
|
0
|
0
|
-
|
|
Hart et al. [28]
|
Medium
|
1/60
|
1/60
|
1.00 (0.06, 16.37)
|
0
|
0
|
-
|
|
Mazoochian et al. [37]
|
Medium
|
4/26
|
3/26
|
1.39 (0.28, 6.95)
| | |
NR
|
|
Rittmeister & Peters [35]
|
Medium
|
7/76
|
6/76
|
1.18 (0.38, 3.70)
| | |
NR
|
|
Speranza et al. [36]
|
Medium
|
3/46
|
0/54
|
8.77 (0.44, 174.38)
|
1/46
|
3/54
|
0.38 (0.04, 3.76)
|
|
DiGioia et al. [17]
|
Medium
|
0
|
0
|
-
|
0
|
0
|
-
|
|
De Beer et al. [25]
|
Medium
|
1/30
|
2/30
|
0.48 (0.04, 5.63)
|
0
|
0
|
-
|
|
Levine et al. [32]
|
Medium
|
14/126
|
13/75
|
0.60 (0.26, 1.35)
| | |
NR
|
|
Nakamura et al. [33]
|
Medium
|
1/50
|
2/42
|
0.41 (0.04, 4.67)
|
4/50
|
5/42
|
0.64 (0.16, 2.57)
|
|
CAS
| | | | | | | |
|
Leenders et al. [16]
|
High
| | |
NR
|
7/50
|
14/50
|
0.42 (0.15, 1.15)
|
|
Parratte & Argenson [40]
|
High
|
0
|
0
|
-
|
6/30
|
17/30
|
0.19 (0.06, 0.60)
|
|
Kalteis et al. [15] (CT-based)
|
High
|
0/30
|
1/30
|
0.32 (0.01, 8.24)
|
5/30
|
16/30
|
0.17 (0.05, 0.58)
|
|
Kalteis et al. [15] (Imageless)
|
High
|
0/30
|
1/30
|
0.32 (0.01, 8.24)
|
2/30
|
16/30
|
0.06 (0.01, 0.31)
|
|
Kalteis et al. [38]
|
Medium
|
0
|
0
|
-
|
2/23
|
11/22
|
0.10 (0.02, 0.51)
|
|
Sugano et al. [41]
|
Medium
|
0/60
|
7/120
|
0.13 (0.01, 2.23)
|
0/59
|
31/111
|
0.02 (0.00, 0.36)
|
|
Najarian et al. [39]
|
Medium
|
2/47
|
2/53
|
1.13 (0.15, 8.38)
|
6/47
|
18/53
|
0.28 (0.10, 0.80)
|
|
Wixson & MacDonald [18]
|
Medium
|
2/82
|
1/50
|
1.23 (0.11, 13.87)
|
17/82
|
18/50
|
0.46 (0.21, 1.02)
|
- No. = number; OR = Odds ratio; 95% CI = 95% confidence interval; NR = outcome measure not reported. † Articles report on the same study population.
- * An OR below 1 with 95% CI indicates lower odds for complications and outliers in favor of the study group.
